FHB
SAGE

First Hawaiian Bank’s Sage Therapeutics SAGE Stock Holding History

First Hawaiian Bank’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-69
Closed -$7K – 1811
2018
Q4 		$7K Sell
69
-30
-30% -$3.43K ﹤0.01% 1550
2018
Q3 		$14K Buy
+99
New +$15.3K ﹤0.01% 1464

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Hawaiian Bank's SAGE Position: Q1 2019 in Review

First Hawaiian Bank sold out of Sage Therapeutics (SAGE) in Q1 2019, closing a stake of 69 shares — an estimated $7K sold.

First Hawaiian Bank first reported a position in SAGE in Q3 2018 and held it in 2 quarters. The position peaked at $14K in Q3 2018. 267 funds tracked by Wall St. Rank hold SAGE as of Q1 2019.

  • First Hawaiian Bank reported no remaining Sage Therapeutics position as of Q1 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 69 Sage Therapeutics shares in Q1 2019, an estimated $7K.
  • First Hawaiian Bank first reported a position in Sage Therapeutics in Q3 2018 and held it in 2 quarters.
  • First Hawaiian Bank's Sage Therapeutics position peaked at $14K in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2019.

Based on First Hawaiian Bank's 13F filing for Q1 2019, filed 2 Apr 2019.